Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yoshihide Ueda
Institutions:
Kakogawa City Hospital Organization,
Kakogawa Central City Hospital
Observed institutions:
Kakogawa City Hospital Organization,
Kakogawa Central City Hospital
ORCID:
0000-0003-3196-3494
Observed ORCID:
0000-0003-3196-3494
OpenAlex ID:
A5122467370
Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child–Pugh Class B: A Real‐World Study
2026
·
Hideko Ohama
, Atsushi Hiraoka
, et al.
·
Hepatology Research
·
6
Lymphocyte–Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab
2026
·
Tomomitsu Matono
, Toshifumi Tada
, et al.
·
Liver International
·
4
Real-World Comparison of First-Line Atezolizumab plus Bevacizumab and Durvalumab plus Tremelimumab for Unresectable Hepatocellular Carcinoma
2026
·
Atsushi Hiraoka
, Toshifumi Tada
, et al.
·
Liver Cancer
·
3
PDF
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab
2026
·
Kazunari Tanaka
, Kunihiko Tsuji
, et al.
·
Hepatology Research
Impact of Frequent Immune‐Mediated Adverse Events on Treatment Continuity and Outcomes During Durvalumab Plus Tremelimumab Therapy for Unresectable Hepatocellular Carcinoma
2026
·
Tomomitsu Matono
, Toshifumi Tada
, et al.
·
Liver international communications.
Hepatologists' Perception of the Recipient Registration Criteria for Deceased Donor Liver Transplantation: A Survey in Hokuriku, Japan
2026
·
Akihiro Seki
, Shintaro Yagi
, et al.
·
Kanzo
PDF
Show more works
View as search
Works count:
6
Citation count:
13
H-index:
3
I10-index:
Year
Topic
Type